Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Aegis Treatment Centers LLC, situated in Stockton, CA, provides outpatient services for substance use disorder and detoxification to adults, youth, and adolescents. This center emphasizes high-quality care, offering outpatient treatments like methadone, buprenorphine, or naltrexone, complemented by 12-step support, anger management, and brief intervention strategies. Aegis Treatment Centers LLC is notable for its dedicated adolescent programs and individualized care plans for men and women. For those looking for scientifically supported addiction treatment in a nurturing setting, this organization is committed to guiding individuals toward lasting recovery.
Aegis Treatment Centers LLC in Pasadena, CA, provides outpatient services for overcoming substance dependency, serving adults and young adults. The center is equipped to offer tailored support for adult males, adult females, and individuals managing HIV or AIDS. Utilizing methods such as 12-step encouragement, emotional regulation strategies, and concise intervention techniques, Aegis Treatment Centers LLC addresses a wide spectrum of client requirements. The organization is committed to delivering excellent addiction recovery solutions within a nurturing and empathetic setting. Both for initial detox needs and sustained substance use care, individuals can access complete treatment plans customized to their unique circumstances at Aegis Treatment Centers LLC.
Aegis Treatment Centers LLC in El Monte, CA, provides outpatient services for detox and addiction treatment. Their specialties include preventing future relapses, offering counseling for substance use disorders, and utilizing virtual therapy options. They have specific programs designed for active military members, adult men, and adult women. The center accommodates adults and young adults of all genders, emphasizing personalized care within a nurturing setting to support individuals on their journey to sobriety.
Aegis Treatment Centers LLC, located in Bakersfield, CA, provides comprehensive outpatient services for individuals struggling with substance use. Their offerings encompass medication-assisted treatment with methadone, buprenorphine, or naltrexone, alongside standard outpatient counseling. Specialized therapies, such as anger management, brief intervention, and cognitive behavioral therapy, are also available. The center serves a diverse clientele, including active duty military members, adult men, and adult women, with a particular focus on providing individualized support to adults and young adults of all genders. Aegis Treatment Centers LLC in Bakersfield is dedicated to delivering high-quality, evidence-based care to promote successful recovery journeys.
Nestled in Redding, CA, Aegis Treatment Centers LLC provides comprehensive outpatient care, including substance use disorder treatment and medication-assisted therapy with methadone, buprenorphine, or naltrexone. Their expertise extends to specialized programs such as anger management, brief intervention, and cognitive behavioral therapy. Aegis Treatment Centers LLC is committed to serving diverse populations, offering tailored services for adult men, adult women, pregnant and postpartum women, and young adults. They foster a nurturing atmosphere for both male and female adults pursuing recovery. Aegis Treatment Centers LLC utilizes scientifically-backed methods to empower individuals on their journey to sobriety, standing as a symbol of accessible and individualized recovery solutions.
Aegis Treatment Centers LLC in Ventura, CA, provides outpatient services for adults and young adults to address substance use disorders. They offer specialized programs for active military personnel, adult men, and adult women, ensuring care is customized to individual requirements. Their treatment methods include 12-step facilitation, anger management, and brief intervention, all aimed at promoting comprehensive recovery. Aegis Treatment Centers LLC, which serves both genders, is dedicated to high-quality, personalized treatment plans designed to aid in successful recovery. For those in Ventura looking for thorough addiction treatment, this center offers evidence-based care and supportive assistance.
Aegis Treatment Centers LLC in Bakersfield, CA, delivers outpatient services for individuals struggling with substance use disorders. Their offerings include medication-assisted treatment utilizing methadone, buprenorphine, or naltrexone. The center employs evidence-based therapeutic modalities such as 12-step program support, anger management techniques, and brief intervention strategies. Aegis Treatment Centers LLC is dedicated to serving specific populations, including active military personnel, adult men, and adult women, with tailored programs. They welcome adults and young adults of all genders seeking effective recovery solutions. The facility is committed to providing excellent care and robust support for those on their journey to sobriety.
Aegis Treatment Centers LLC in Chico, CA, is a premier establishment dedicated to assisting adults and young adults in overcoming substance dependency. Their services encompass outpatient treatment utilizing methadone, buprenorphine, or naltrexone, along with standard outpatient programs. They also employ specialized strategies like contingency management, the Matrix Model, and motivational interviewing to craft individualized care. Aegis Treatment Centers LLC offers specific support for active duty military members, as well as separate programs for adult men and adult women. The center distinguishes itself through its commitment to personalized treatment frameworks and scientifically validated therapeutic methods, ensuring high standards of care for all clients, regardless of gender.
Aegis Treatment Centers LLC in Hesperia, CA, delivers outpatient care for individuals grappling with substance use disorders and co-occurring mental health conditions. The program encompasses outpatient medication-assisted treatment utilizing methadone, buprenorphine, or naltrexone, supported by proven therapeutic methods like 12-step program integration, anger management techniques, and brief counseling strategies. Personalized treatment plans are available for both adults and young adults, acknowledging their unique needs. Aegis Treatment Centers LLC is committed to providing high-quality, all-encompassing assistance to guide individuals toward sustained sobriety and well-being. For those in need of effective addiction support in a supportive setting, Aegis Treatment Centers LLC in Hesperia is a viable option.
Aegis Treatment Centers LLC, located in Marysville, CA, delivers outpatient services for chemical dependency and substance abuse, serving adults and adolescents. The center features targeted interventions for expectant and new mothers, with distinct care plans for male and female patients. Employing therapeutic modalities such as cognitive behavioral therapy, motivational incentives, and the Matrix Model, Aegis Treatment Centers LLC prioritizes scientifically supported methods for successful rehabilitation. The facility also provides outpatient medication-assisted treatment using methadone, buprenorphine, or naltrexone, addressing a broad spectrum of recovery requirements. For those in Marysville requiring thorough and individualized addiction recovery support, Aegis Treatment Centers LLC is committed to guiding individuals toward sustained wellness.
Aegis Treatment Centers LLC, located in Atascadero, CA, specializes in outpatient services for substance abuse and co-occurring mental health conditions in adults, and emotional disturbances in children. Their treatment methods include 12-step facilitation, anger management, and brief intervention strategies to deliver thorough support. The center offers distinct programs for active duty military, adult men, and women, acknowledging varied requirements. Aegis is committed to providing personalized and high-quality care to adults and young adults of all genders, making it a trusted option for those pursuing effective and caring addiction recovery in Atascadero.
Aegis Treatment Centers LLC, located in Delano, CA, provides comprehensive outpatient services for individuals battling substance use disorders. Their programs encompass detoxification and ongoing treatment, serving both adult and adolescent populations. With expertise in anger management techniques, cognitive behavioral therapy, and the structured Matrix Model, Aegis Treatment Centers LLC welcomes clients of all genders. They also offer tailored support for expectant and new mothers, as well as those involved with the criminal justice system. The center is committed to delivering high-quality, personalized care designed to facilitate lasting recovery. Aegis Treatment Centers LLC is a suitable option for those in need of outpatient treatment utilizing methadone, buprenorphine, or naltrexone within a nurturing setting.
Aegis Treatment Centers LLC, located in Grass Valley, CA, specializes in outpatient services for adults and young adults seeking to recover from substance use disorders. Their program includes medication-assisted treatment with methadone, buprenorphine, or naltrexone, complemented by therapeutic interventions such as 12-step support, anger management techniques, and brief counseling. The center is particularly attentive to the needs of pregnant and postpartum women, serving both male and female individuals. Aegis Treatment Centers LLC is committed to delivering effective and compassionate care within a supportive and professional setting for those pursuing sobriety.
Aegis Treatment Centers LLC in Oxnard, CA, specializes in outpatient care for adults and young adults struggling with substance use. The center provides medication-assisted treatment, including methadone, buprenorphine, and naltrexone, alongside therapeutic interventions like 12-step facilitation, anger management, and brief intervention strategies. Aegis Treatment Centers LLC in Oxnard offers targeted programs for active duty military personnel, men, and women, ensuring a supportive and inclusive environment for all clients. Their approach emphasizes personalized treatment plans and specialized programs to guide individuals toward lasting recovery.
Aeschbach and Associates Inc. in Austin, TX offers thorough outpatient care for those needing detox and help with substance use. They have expertise with dual diagnoses and provide outpatient detox and medication-assisted treatment options. Their programs include anger management, brief counseling, and cognitive behavioral therapy, specifically designed for adult women who have experienced intimate partner violence, domestic abuse, or sexual assault. They welcome adults and younger individuals of any gender, delivering personalized, evidence-based support for their recovery journey.
Affect Therapeutics, situated in Ballwin, MO, provides outpatient treatment for substance use disorders aimed at both adults and young adults. The center employs targeted methods including contingency management, motivational interviewing, and the Matrix Model to ensure specialized care. Prioritizing personalized treatment plans, Affect Therapeutics customizes its programs to address the diverse requirements of each individual. In addition to standard outpatient services, the facility offers methadone/buprenorphine or naltrexone treatment, ensuring a holistic approach to recovery. Catering to both men and women, Affect Therapeutics is dedicated to offering high-quality care in a nurturing setting, making it a prime option for those in need of effective and tailored addiction recovery solutions.
Situated in Portland, OR, Affect Therapeutics provides outpatient treatment for substance use specifically designed for both adults and young adults. The facility offers specialized outpatient services that include methadone/buprenorphine or naltrexone therapy, along with standard outpatient care. Employing proven methods like contingency management/motivational incentives, the Matrix Model, and motivational interviewing, they guarantee a thorough and customized treatment experience. Affect Therapeutics distinguishes itself through its commitment to individualized care, accommodating clients of all genders. For those in need of effective and empathetic addiction treatment, this center is committed to aiding your path to recovery.
Affect Therapeutics in New Berlin, WI, is a dedicated facility providing expert care for individuals grappling with substance use disorders and co-occurring mental health conditions, catering to both adults and youth. They offer robust intensive outpatient and outpatient services, incorporating medication-assisted treatments such as methadone, buprenorphine, and naltrexone to support recovery. Employing proven therapeutic modalities, including Contingency Management, the Matrix Model, and Motivational Interviewing, the center prioritizes crafting personalized treatment strategies. Affect Therapeutics welcomes adults and young adults of all gender identities, distinguishing itself through its customized programs and unwavering dedication to high-quality, individual-focused recovery support. If you are in search of impactful and personalized addiction treatment, Affect Therapeutics is committed to guiding you toward lasting recovery.
Affect Therapeutics Inc, located in Danville, KY, is dedicated to providing outpatient treatment for substance use issues among adults and young adults. The center offers a variety of services, including outpatient programs featuring methadone, buprenorphine, or naltrexone, along with traditional outpatient therapy, all tailored to meet individual needs. The facility employs evidence-supported techniques like motivational interviewing, contingency management, and the Matrix Model to deliver thorough assistance to both men and women. With a focus on high-quality, customized care, Affect Therapeutics Inc is a reliable choice for individuals in search of compassionate and effective support for addiction recovery.
Affect Therapeutics Inc, situated in Tucson, Arizona, specializes in outpatient treatment for substance abuse targeted at both adults and young adults. This center offers a variety of tailored programs, which include outpatient treatment with methadone, buprenorphine, or naltrexone, as well as standard outpatient services. Adopting evidence-supported methods like motivational interviewing, contingency management, and the Matrix Model, the facility is committed to providing high-quality care for clients of all genders. With an emphasis on personalized treatment strategies within a nurturing environment, Affect Therapeutics Inc is focused on assisting individuals in their recovery journey.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.